Decisio Health is a technology service provider that facilitates remote patient monitoring and clinical monitoring support services. Its OpticsIQ solution helps clinicians enable remote patient monitoring and virtual consultations, consolidates and prioritizes real-time patient-related data from any device, and helps with identifying at-risk patients through its inbuilt analytics system. The platform, which is an FDA 510(k) Class II cleared medical device, can be focused on a single area of care or scaled across the entire health system.
The Texas-based company operates on a B2B basis, where it offers its solutions to healthcare providers and large hospital systems in the US. Decisio offers remote care providers access to real-time patient information from multiple sources, and combines this with the hospital’s parameters and protocols. This information is used to support clinical decisions.
In March 2022, the company raised USD 18.5 million in a Series B funding round. The raised funds are to be used for commercialization, improving its platform and growing operations. This brings the total funds raised by the company to USD 31.5 million.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.